Here, we described an assay to detect AXL expression on the surface of CTCs from patients with mBC using the CellSearch® system, the only FDA‐approved method to detect CTCs in metastatic breast, prostate, and colon cancer.35, 36, 37. The gene discussed is AXL; the disease is malignant colon neoplasm.